Yuankai Shi, Haiqiang Mai, Chuanben Chen, Ying Wang, Jingao Li, Hekun Jin, Xingchen Peng, Peng Zhang, Shenhong Qu, Jianli Huang, Yu-Xiang He, Dong-Ping Chen, Suming Pan, Jinsheng Hong, Ning Zhang, Feng Lei, Desheng Hu, Yan Qing, Xiaoping Jin, Junyou Ge. "Tagitanlimab versus placebo in combination with gemcitabine and cisplatin as first-line treatment for recurrent or metastatic nasopharyngeal carcinoma (R/M NPC): Results from a randomized, double-blind, phase 3 study.." Journal of Clinical Oncology, 2025. doi:10.1200/jco.2025.43.16_suppl.6004